ARGNF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Argen X (ARGNF) Ownership - Who owns Argen X?

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Laarderhoogtweg 25

Phone

+31 107038441

Employees

1148

Web

https://www.argenx.com

Details

Group

Domestic Stock Funds

Fundamentals

ARGNF

Capitalization

36.8B

P/E Ratio

54.57

Risk (Beta)

-0.39

Dividend Yield

N/A

Total Cash

3.1B

Total Cash/Share

50.81

Total Debt

34M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

33.60%

Revenue

1.86B

ROE

N/A

Book Value

4.26B

P/B Ratio

7.75

Cash Flow

N/A

Earnings

-0.7

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

7.12M

Current Ratio

8.53

Current Revenue Per Employee

499334.50

Dividends Per Share - Security

N/A

EBITDA

-60.47M

Float

N/A

Float - Current

N/A

Gross Income Margin

89.69

Revenue To Assets

-5.11

Shares Held By Institutions

22.7B

Shares Outstanding - Current

61.1M

Total Liabilities

534M

Total Volume MTD

N/A

Value

-1

Gain YTD

6.909

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology